Noom Review: What You Actually Get
A behaviour-change app that added a GLP-1 arm. The psychology curriculum is the real product; the medication program sits on top of it at $349/month after the introductory period.
How we're paid: Some links on this site are affiliate links, and we earn a commission when readers sign up through them. Every figure below was taken from Noom's own published pages on the date shown, and is listed with its source at the bottom of this review. Full disclosure →
Overview
Noom arrived at GLP-1 medication from an unusual direction. It spent a decade building a behaviour-change program rooted in cognitive behavioural psychology — food logging, daily lessons, coaching — and then added a prescription arm, Noom GLP-1Rx, on top of that foundation. Understanding the company in that order explains most of what is good and bad about the medication offering.
Noom offers both brand-name products (Ozempic, Wegovy, Mounjaro, Zepbound) and compounded semaglutide and tirzepatide through GLP-1Rx and a separate Microdose program. The company is explicit that medications in the GLP-1Rx program "are produced in USP-compliant, state-regulated pharmacies but not reviewed by the FDA" — clearer language than many competitors use about what compounded means.
Pricing is where prospective members should slow down. The advertised entry point is $149 for an initial three-week subscription plus four weeks of medication, which reads cheap. The ongoing rate is $349/month plus tax on a twelve-week subscription. That is among the higher recurring prices in compounded GLP-1 telehealth, and the introductory framing obscures it.
Medications Offered
Brand-name (FDA-approved)
- •Ozempic (semaglutide)
- •Wegovy (semaglutide)
- •Mounjaro (tirzepatide)
- •Zepbound (tirzepatide)
Compounded
- •Compounded semaglutide (GLP-1Rx and Microdose programs)
- •Compounded tirzepatide (GLP-1Rx and Microdose programs)
Noom states that medications in the GLP-1Rx program are produced in USP-compliant, state-regulated pharmacies but are not reviewed by the FDA. The separate Microdose program uses lower doses than standard titration schedules; Noom does not publish the clinical rationale or supporting evidence for microdosing on the pages we reviewed, and it is not an FDA-approved dosing approach. We cover what the clinical sources actually say about microdosing in a separate guide.
How the Program Works
Consultation process
Entirely online. Noom advertises "100% online access to coaches and doctors" and "unlimited chat with our doctors." There is no video-visit requirement described on the pages we reviewed.
Eligibility
Noom states you cannot use the service if you are under 18, pregnant, have an eating disorder, or are underweight with a BMI below 18.5. The company also notes that "not all customers will qualify for a prescription." Positive qualifying criteria — the BMI or comorbidity thresholds that would make you eligible — are not published.
Provider involvement
Doctors are reachable by unlimited chat, and Noom pairs the clinical relationship with its coaching program. The medication arm is layered onto the behaviour-change curriculum rather than replacing it.
Lab requirements
Not stated on the pages we reviewed.
Pharmacy fulfillment
Noom describes USP-compliant, state-regulated pharmacies for its compounded products but does not name specific partners on the pages we reviewed.
Shipping
Not stated on the pages we reviewed.
Support services
This is Noom's strength. The subscription includes the psychology-based curriculum, daily lessons, food logging, and human coaching — a genuinely developed behavioural program rather than a token app.
Insurance
Noom offers a "GLP-1 Insurance Checker" tool. The pages we reviewed do not state how coverage is processed, whether Noom bills insurers, or whether the subscription itself is ever covered.
Pricing
Membership fee
Noom bundles subscription and medication into program pricing rather than charging a separate membership. The standard GLP-1Rx program runs $149 plus tax for an initial three-week subscription and four weeks of medication, then $349/month plus tax on a twelve-week subscription. Noom Weight, the app-only behaviour program, is priced separately with a free trial.
| Medication / plan | Published price | Notes |
|---|---|---|
| GLP-1Rx — introductory | From $149 + tax | Initial 3-week subscription and 4 weeks of medication |
| GLP-1Rx — ongoing | $349/mo + tax | 12-week subscription |
| Microdose GLP-1Rx | $49 | Limited-time offer; Noom states price includes medication |
| Noom Weight (app only) | Varies | Free trial available; no medication included |
| Brand-name GLP-1s | Not published | Noom offers an insurance checker tool |
Prices as published by Noom on August 5, 2026. Telehealth pricing changes often, and promotional first-month rates are common. Check the provider's own page before you commit. The $49 Microdose figure is described by Noom as a limited-time offer.
Cancellation, Refunds & Payment
Cancellation policy
Not stated on the pages we reviewed. Given that the standard program is sold as a twelve-week subscription, clarify the terms of exiting mid-term before enrolling.
Refund policy
Not stated on the pages we reviewed.
HSA / FSA
Not stated on the pages we reviewed.
Insurance handling
Noom offers a "GLP-1 Insurance Checker" tool. The pages we reviewed do not state how coverage is processed, whether Noom bills insurers, or whether the subscription itself is ever covered.
What We Like
The behavioural program is real, and it predates the medication
Noom did not bolt a curriculum onto a pill mill; it added medication to a decade-old behaviour-change product. If you believe — as most obesity medicine does — that medication works better alongside sustained behavioural support, that ordering is the right one.
Honest language about what compounded means
Stating that medications are "produced in USP-compliant, state-regulated pharmacies but not reviewed by the FDA" is clearer than the vague reassurance many competitors offer. It tells you exactly what regulatory status you are getting.
Clear disqualifying criteria
Noom publishes who cannot use the service — under 18, pregnant, active eating disorder, BMI below 18.5. Screening out underweight users and people with eating disorders is a basic safety posture, and saying so publicly is worth something.
Both brand and compounded pathways exist
Ozempic, Wegovy, Mounjaro, and Zepbound are all available alongside compounded options, so an insurance win does not mean switching providers.
What We'd Improve
The ongoing price is high, and the headline hides it
$349/month plus tax is at the top of the compounded GLP-1 market — roughly three times what Mochi, Found, or Coreage RX charge to start. Advertising a $149 entry point that covers three weeks of subscription and four weeks of medication makes that harder to see than it should be.
Microdosing is offered without published justification
Noom markets a Microdose program at a $49 introductory price but does not publish the clinical rationale or the evidence behind it. Sub-therapeutic GLP-1 dosing is not an FDA-approved approach, and a program built on it should explain itself.
Almost nothing published on the operational details
No lab requirements, no named pharmacies, no shipping timelines, no cancellation terms, no refund policy. For a twelve-week subscription commitment, the absence of published cancellation terms is the gap that matters most.
Insurance handling is a tool, not a service
An insurance checker tells you what your plan might cover. It does not file prior authorisations or contract with carriers, which is what platforms like Found and LifeMD actually do.
Who It May Be Best For
Worth considering if you:
- •Want structured behavioural change alongside medication, not just a prescription
- •Have used and liked Noom's app-based program already
- •Value plain language about the regulatory status of compounded drugs
- •Want unlimited asynchronous access to clinicians and coaches
- •Are willing to pay a premium for the curriculum and coaching layer
Probably not if you:
- •Are optimising for the lowest monthly cost — this is roughly 3× the cheapest compounded programs
- •Want a month-to-month arrangement rather than a twelve-week subscription
- •Need published cancellation and refund terms before committing
- •Want a provider that actively works your insurance claim
- •Are uncomfortable with a microdosing program that does not publish its evidence base
Limitations of This Review
- •We reviewed Noom's published pages rather than enrolling, so we cannot assess coaching quality, clinician responsiveness, or how the Microdose program is managed in practice.
- •Noom does not publish lab requirements, pharmacy partners, shipping details, cancellation terms, or a refund policy, so those sections reflect gaps in disclosure.
- •Introductory pricing is explicitly time-limited and the structure — three weeks of subscription bundled with four weeks of medication — does not map cleanly onto a monthly comparison.
- •We take no position on whether Noom's behavioural curriculum improves GLP-1 outcomes. That question has not been settled by trial evidence for any specific commercial program.
Alternatives
Calibrate
The other program built around coaching and curriculum rather than medication alone, with metabolic lab testing included.
Mochi Health
Compounded semaglutide from $99 plus a $79/month membership — a far lower recurring cost for the medication pathway.
Found
If insurance coverage is realistic for you, Found contracts with carriers rather than just checking benefits.
WeightWatchers Med+
The closest comparison: a behaviour-change brand with a clinical arm, at $74–$84/month for membership.
Our Verdict
Noom is the rare weight platform where the non-medication half is genuinely substantial. The psychology curriculum and coaching are the product the company actually built, and if that support is what you want, no compounding-first competitor offers an equivalent.
The pricing is the problem. $349/month plus tax is roughly three times what Mochi Health, Found, or Coreage RX charge to start on compounded semaglutide, and the $149 introductory offer — three weeks of subscription with four weeks of medication — is structured in a way that makes the real recurring cost hard to see at the point of sign-up.
We are also uneasy about the Microdose program. Marketing a $49 entry price for a dosing approach that is not FDA-approved, without publishing the clinical reasoning behind it, is the kind of thing that deserves an explanation rather than a discount.
Worth considering if the behavioural program is the reason you are here and the price is one you have deliberately chosen to pay. If you want the medication and a competent clinician, you can get both for a third of the money elsewhere.
Frequently Asked Questions
How much does Noom's GLP-1 program cost per month?+
Noom states the GLP-1Rx program starts at $149 plus tax for an initial three-week subscription and four weeks of medication, then $349/month plus tax on a twelve-week subscription. A separate Microdose program is advertised at a $49 limited-time offer that Noom says includes medication.
What is Noom's Microdose program?+
It is a program using lower GLP-1 doses than standard titration schedules, advertised at a $49 introductory price with medication included. Noom does not publish the clinical rationale or supporting evidence on the pages we reviewed. Microdosing is not an FDA-approved dosing approach, and it is a reasonable thing to ask a clinician about directly before starting.
Are Noom's compounded medications FDA-approved?+
No. Noom states that medications included in the GLP-1Rx program are produced in USP-compliant, state-regulated pharmacies but are not reviewed by the FDA. That is accurate: compounded drugs are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
Who cannot use Noom's GLP-1 program?+
Noom states you cannot use the service if you are under 18, pregnant, have an eating disorder, or are underweight with a BMI below 18.5. The company also notes that not all customers will qualify for a prescription.
Does Noom take insurance?+
Noom provides a GLP-1 Insurance Checker tool. The pages we reviewed do not state that Noom bills insurers, contracts with carriers, or files prior authorisations on your behalf.
Do I have to use the Noom app to get medication?+
The GLP-1Rx program is sold as a subscription that includes Noom's coaching and curriculum, so the behavioural program is part of what you are paying for. If you want medication without the curriculum, a medication-focused platform will cost considerably less.
Where These Facts Came From
Every price, medication, and policy above was read directly from these pages on August 5, 2026. Where a provider does not publish something, we say so rather than estimate it.
Compare This Against Every Other Provider
Side-by-side pricing, medication access, and support for the platforms we've reviewed.
Compare All Providers🇺🇸Medical Disclaimer
Your health, your doctor. This review is information, not medical advice. We're researchers and reviewers, not clinicians. GLP-1 medications are prescription drugs that require physician oversight, and they aren't appropriate for everyone. Talk to your healthcare provider about whether this class of medication fits your health situation. Individual responses vary significantly. Reviewed August 5, 2026.